Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will...
How might the Q2 results affect the valuation multiples (e.g., P/E, EV/EBITDA) relative to the broader market and sector peers?
What are the potential upside or downside risks highlighted by management that could influence the stock price?
Did the company address any competitive threats or emerging technologies that could affect its market position?
27 days ago